The amount of ECM1 produced by hepatocytes is reduced when liver fibrosis occurs, while exogenous ECM1 supplementation can reverse hepatofibrosis by blocking HSC activation [28]. This evidence concerns the gene ECM1 and Hepatic fibrosis.